IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells

A recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Beca...

Full description

Bibliographic Details
Main Authors: Yafei Zhang, Bicheng Zhang, Anran Zhang, Xiaohua Li, Jian Liu, Jie Zhao, Yong Zhao, Jianfei Gao, Dianchun Fang, Zhiguo Rao
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2013-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032&lng=en&tlng=en
_version_ 1818545435219853312
author Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
author_facet Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
author_sort Yafei Zhang
collection DOAJ
description A recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Because miR-26a expression was found to be transcriptionally downregulated by oncogene c-Myc in various cancers, and the expression of c-Myc was increased by IL-6 stimulation, we hypothesized that IL-6 contributes to reduction of miR-26a in hepatocellular carcinoma. Serum IL-6 was measured by ELISA and miR-26a was detected by qRT-PCR. The data of 30 patients with hepatocellular carcinoma who had undergone surgical tumor resection revealed that serum IL-6 could be considered to be a predictor of survival up to 5 years for hepatocellular carcinoma patients (log-rank test, P < 0.05). We observed that the serum IL-6 concentration was inversely correlated with miR-26a expression in cancerous tissues (Pearson correlation test, r = -0.651, P < 0.01). Furthermore, by in vitro experiments with HepG2 cells, we showed that IL-6 stimulation can lead to miR-26a suppression via c-Myc activation, whereas in normal hepatocyte LO2 cells incubation with IL-6 had no significant effect on miR-26a expression. Taken together, these results indicate that miR-26a reduction in hepatocellular carcinoma might be due to IL-6 upregulation.
first_indexed 2024-12-12T07:40:11Z
format Article
id doaj.art-1d2539d9fe224032ac7171686be22834
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-12-12T07:40:11Z
publishDate 2013-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-1d2539d9fe224032ac7171686be228342022-12-22T00:32:48ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2013-01-01461323810.1590/S0100-879X2012007500155S0100-879X2013000100032IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cellsYafei ZhangBicheng ZhangAnran ZhangXiaohua LiJian LiuJie ZhaoYong ZhaoJianfei GaoDianchun FangZhiguo RaoA recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Because miR-26a expression was found to be transcriptionally downregulated by oncogene c-Myc in various cancers, and the expression of c-Myc was increased by IL-6 stimulation, we hypothesized that IL-6 contributes to reduction of miR-26a in hepatocellular carcinoma. Serum IL-6 was measured by ELISA and miR-26a was detected by qRT-PCR. The data of 30 patients with hepatocellular carcinoma who had undergone surgical tumor resection revealed that serum IL-6 could be considered to be a predictor of survival up to 5 years for hepatocellular carcinoma patients (log-rank test, P < 0.05). We observed that the serum IL-6 concentration was inversely correlated with miR-26a expression in cancerous tissues (Pearson correlation test, r = -0.651, P < 0.01). Furthermore, by in vitro experiments with HepG2 cells, we showed that IL-6 stimulation can lead to miR-26a suppression via c-Myc activation, whereas in normal hepatocyte LO2 cells incubation with IL-6 had no significant effect on miR-26a expression. Taken together, these results indicate that miR-26a reduction in hepatocellular carcinoma might be due to IL-6 upregulation.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032&lng=en&tlng=enMiR-26aIL-6c-MycHepatocellular carcinomaCarcinoma prognosis
spellingShingle Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
Brazilian Journal of Medical and Biological Research
MiR-26a
IL-6
c-Myc
Hepatocellular carcinoma
Carcinoma prognosis
title IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
title_full IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
title_fullStr IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
title_full_unstemmed IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
title_short IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
title_sort il 6 upregulation contributes to the reduction of mir 26a expression in hepatocellular carcinoma cells
topic MiR-26a
IL-6
c-Myc
Hepatocellular carcinoma
Carcinoma prognosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032&lng=en&tlng=en
work_keys_str_mv AT yafeizhang il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT bichengzhang il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT anranzhang il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT xiaohuali il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT jianliu il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT jiezhao il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT yongzhao il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT jianfeigao il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT dianchunfang il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells
AT zhiguorao il6upregulationcontributestothereductionofmir26aexpressioninhepatocellularcarcinomacells